ciprofloxacin has been researched along with Swine Diseases in 21 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Swine Diseases: Diseases of domestic swine and of the wild boar of the genus Sus.
Excerpt | Relevance | Reference |
---|---|---|
"All ciprofloxacin MICs were below the ECOFF (≤ 1 μg/mL), except for three isolates from untreated sows and four isolates after aminopenicillin therapy." | 1.38 | Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values. ( Hänninen, ML; Heiska, H; Juntunen, P, 2012) |
"Danofloxacin-treated (n=12, group A) and control pigs (n=15, group B) were subsequently treated with tylosin and sampled longitudinally." | 1.37 | Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments. ( Hänninen, ML; Juntunen, P; Olkkola, S, 2011) |
"The impact of Actinobacillus pleuropneumoniae (APP) infection in swine on the pharmacokinetic parameters of enrofloxacin were determined." | 1.31 | Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. ( Baker, JD; Cope, CV; Farrell, DE; Myers, MJ; Post, LO, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 8 (38.10) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
McGuirk, PR | 1 |
Jefson, MR | 1 |
Mann, DD | 1 |
Elliott, NC | 1 |
Chang, P | 1 |
Cisek, EP | 1 |
Cornell, CP | 1 |
Gootz, TD | 1 |
Haskell, SL | 1 |
Hindahl, MS | 1 |
Liu, JH | 2 |
Deng, YT | 1 |
Zeng, ZL | 1 |
Gao, JH | 1 |
Chen, L | 2 |
Arakawa, Y | 1 |
Chen, ZL | 1 |
Nafarrate, I | 1 |
Lasagabaster, A | 1 |
Sevillano, E | 1 |
Mateo, E | 1 |
Chen, CJ | 1 |
Lauderdale, TY | 1 |
Lu, CT | 1 |
Chuang, YY | 1 |
Yang, CC | 1 |
Wu, TS | 1 |
Lee, CY | 1 |
Lu, MC | 1 |
Ko, WC | 1 |
Huang, YC | 1 |
Römer, A | 1 |
Scherz, G | 1 |
Reupke, S | 1 |
Meißner, J | 1 |
Wallmann, J | 1 |
Kietzmann, M | 1 |
Kaspar, H | 1 |
Qiu, H | 1 |
Gong, J | 1 |
Butaye, P | 1 |
Lu, G | 1 |
Huang, K | 1 |
Zhu, G | 1 |
Zhang, J | 1 |
Hathcock, T | 1 |
Cheng, D | 1 |
Wang, C | 1 |
Perez, F | 1 |
Rudin, SD | 1 |
Marshall, SH | 1 |
Coakley, P | 1 |
Kreiswirth, BN | 1 |
Rather, PN | 1 |
Hujer, AM | 1 |
Toltzis, P | 1 |
van Duin, D | 1 |
Paterson, DL | 1 |
Bonomo, RA | 1 |
Jiu, Y | 1 |
Zhu, S | 1 |
Khan, SB | 1 |
Sun, M | 1 |
Zou, G | 1 |
Meng, X | 1 |
Wu, B | 1 |
Zhou, R | 1 |
Li, S | 1 |
Taylor, NM | 1 |
Davies, RH | 1 |
Ridley, A | 1 |
Clouting, C | 1 |
Wales, AD | 1 |
Clifton-Hadley, FA | 1 |
Opapeju, FO | 1 |
Krause, DO | 2 |
Payne, RL | 1 |
Rademacher, M | 1 |
Nyachoti, CM | 2 |
Qin, SS | 1 |
Wu, CM | 1 |
Wang, Y | 2 |
Jeon, B | 1 |
Shen, ZQ | 1 |
Zhang, Q | 1 |
Shen, JZ | 1 |
Juntunen, P | 2 |
Olkkola, S | 1 |
Hänninen, ML | 2 |
Heiska, H | 1 |
Tamang, MD | 1 |
Nam, HM | 1 |
Chae, MH | 1 |
Kim, SR | 1 |
Gurung, M | 1 |
Jang, GC | 1 |
Jung, SC | 1 |
Lim, SK | 1 |
Wong, MH | 1 |
Zeng, L | 1 |
Chen, S | 1 |
Kiarie, E | 1 |
Scott, M | 1 |
Khazanehei, H | 1 |
Khafipour, E | 1 |
Frana, TS | 1 |
Carlson, SA | 1 |
Rauser, DC | 1 |
Jones, BD | 1 |
Fergen, BJ | 1 |
Griffith, RW | 1 |
Thakur, S | 1 |
Gebreyes, WA | 1 |
Grobbel, M | 1 |
Lübke-Becker, A | 1 |
Wieler, LH | 1 |
Froyman, R | 1 |
Friederichs, S | 1 |
Filios, S | 1 |
Cavaco, LM | 1 |
Frimodt-Møller, N | 1 |
Hasman, H | 1 |
Guardabassi, L | 1 |
Nielsen, L | 1 |
Aarestrup, FM | 1 |
Post, LO | 1 |
Cope, CV | 1 |
Farrell, DE | 1 |
Baker, JD | 1 |
Myers, MJ | 1 |
2 trials available for ciprofloxacin and Swine Diseases
Article | Year |
---|---|
Effect of dietary protein level on growth performance, indicators of enteric health, and gastrointestinal microbial ecology of weaned pigs induced with postweaning colibacillosis.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Ciprofloxac | 2009 |
Interactions of Saccharomyces cerevisiae fermentation product and in-feed antibiotic on gastrointestinal and immunological responses in piglets challenged with Escherichia coli K88+.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Diet; Drug Resistance, Bacteri | 2012 |
19 other studies available for ciprofloxacin and Swine Diseases
Article | Year |
---|---|
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Aerobiosis; Anaerobiosis; Animals; Anti- | 1992 |
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Prote | 2008 |
Prevalence, molecular typing and antimicrobial susceptibility of Campylobacter spp. isolates in northern Spain.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; | 2021 |
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams | 2018 |
Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica).
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Susceptibility; Enrofloxacin; Escherichia col | 2017 |
CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
Topics: Amino Acid Motifs; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; CRISPR-Cas Systems; DNA | 2018 |
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple, | 2013 |
Phenotypic and Genotypic Resistance of Salmonella Isolates from Healthy and Diseased Pigs in China During 2008-2015.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cefotaxime; China; Ciprofloxacin; Drug Resistance, | 2017 |
A survey of fluoroquinolone resistance in Escherichia coli and thermophilic Campylobacter spp. on poultry and pig farms in Great Britain.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr | 2008 |
Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Campylobacter coli; China; Ciprofloxacin; Clindamycin; Dr | 2011 |
Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Ciprofl | 2011 |
Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Campylobacter coli; Campyl | 2012 |
Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; Cluster Analysis; DNA Gyrase | 2012 |
Characterization of Salmonella food isolates with concurrent resistance to ceftriaxone and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; China; Ciprofloxac | 2013 |
Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype typhimurium in pigs.
Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Ciprofloxacin; Cloning, Molecular; Colony Count, Micro | 2004 |
Campylobacter coli in swine production: antimicrobial resistance mechanisms and molecular epidemiology.
Topics: Abattoirs; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infe | 2005 |
Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cattle; Cattle Diseases; Ciprofloxac | 2007 |
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Denmark; Drug Resistance, Bacteri | 2008 |
Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Infective Agents; Anti-Inf | 2002 |